medi-5752,pembrolizumab,medi-5752
astrazeneca,merck
['lcsm,(-blcsm)', 'nsclc', 'medi5752 ', 'medi5752', 'sclc', 'pembro']
medi5752 (bi-antipd1-ctla4 antibody) + chemotherapy vs pembrolizumab + chemotherapy in 1l nsclc. a phase 1b/2 trial. interesting efficacy signal. dose: 750mg better safety profile than 1500 mg. #lcsm #esmo22 
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm